Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients-authors' response.

IF 3.9 2区医学 Q1 INFECTIOUS DISEASES Journal of Antimicrobial Chemotherapy Pub Date : 2024-10-07 DOI:10.1093/jac/dkae357

Tzong-Yow Wu, Pao-Yu Chen, Jann-Tay Wang, Wang-Da Liu, Yee-Chun Chen, Shan-Chwen Chang

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

免疫功能低下患者持续感染 SARS-CoV-2 后，对替卡西单抗/西格维单抗和雷米替韦联合疗法的反应不理想--作者的回应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Antimicrobial Chemotherapy 医学-传染病学

CiteScore

9.20

自引率

5.80%

发文量

423

审稿时长

2-4 weeks

期刊介绍： The Journal publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, and articles in veterinary medicine likely to have an impact on global health.

期刊最新文献

Comparative evaluation of eravacycline susceptibility testing methods in 587 clinical carbapenem-resistant Acinetobacter baumannii isolates: broth microdilution, MIC test strip and disc diffusion. Efficacy and tolerability of high-dose cefalexin 45 mg/kg/dose (maximum 1.5 g) three times daily in children with bone and joint infections. Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting. Comment on: Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. Insights into interspecies protein binding variability using clindamycin as an example.